Estimated antiretroviral therapy coverage among children in EMR
EMR: Estimated antiretroviral therapy coverage among children was 40 in 2025. ◆ Volatile
Latest (2025)
40
Change on year
up 17.6%
Rank
6th
of 7 groups
All-time high
40
in 2025
All-time low
0
in 2000
Years of data
26
2000–2025
Estimated antiretroviral therapy coverage among children in EMR, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
EMR recorded 40 for estimated antiretroviral therapy coverage among children in 2025. That is the highest value across all 26 years on record.
The figure is up 17.6% on the previous year and up 150.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among children in EMR peaked at 40 in 2025 and was at its lowest, 0, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among children in EMR, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0 | — |
| 2001 | 0 | — |
| 2002 | 0 | — |
| 2003 | 1 | — |
| 2004 | 1 | +0.0% |
| 2005 | 2 | +100.0% |
| 2006 | 2 | +0.0% |
| 2007 | 3 | +50.0% |
| 2008 | 5 | +66.7% |
| 2009 | 6 | +20.0% |
| 2010 | 8 | +33.3% |
| 2011 | 8 | +0.0% |
| 2012 | 9 | +12.5% |
| 2013 | 11 | +22.2% |
| 2014 | 14 | +27.3% |
| 2015 | 16 | +14.3% |
| 2016 | 18 | +12.5% |
| 2017 | 20 | +11.1% |
| 2018 | 22 | +10.0% |
| 2019 | 30 | +36.4% |
| 2020 | 31 | +3.3% |
| 2021 | 32 | +3.2% |
| 2022 | 31 | -3.1% |
| 2023 | 34 | +9.7% |
| 2024 | 34 | +0.0% |
| 2025 | 40 | +17.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2 | 0 | 6 | 10 |
| 2010s | 15.6 | 8 | 30 | 10 |
| 2020s | 33.67 | 31 | 40 | 6 |
Countries ranked near EMR
More health data for EMR
- Mortality rate among children ages 5 to 9 years 3.61 (2024)
- Population with primary reliance on polluting fuels and technologies 172.72 (2023)
- Prevalence of diabetes, crude 20.38 (2022)
- Population with primary reliance on fuels and technologies for 153.85 (2023)
- Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 88.0% (2025)
- Measles-containing-vaccine first-dose (MCV1) immunization coverage 81.0% (2025)
- New HIV infections 0.1 (2025)
- Stunting prevalence among children under 5 years of age (%) 26.0% (2024)
- Mean total cholesterol, crude 4.3 (2018)
- Adolescent mortality rate 2.66 (2021)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among children in EMR?
- Estimated antiretroviral therapy coverage among children in EMR was 40 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among children recorded in EMR?
- The highest recorded value was 40 in 2025.
- What is the lowest estimated antiretroviral therapy coverage among children recorded in EMR?
- The lowest recorded value was 0 in 2000.
- How does EMR rank for estimated antiretroviral therapy coverage among children?
- EMR ranks 6th out of 7 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among children rising or falling in EMR?
- Over the last ten years it is up 150.0%. The long-run trend across the full record is volatile.
- Where does this EMR data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among children. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).